75A50126F61002↗

Name: 75A50126F61002: Rtor Bio-Amt-2312: Assessment of the Therapeutic Potential of Chloroquine and Oseltamivir in Two (2) Lethal Models of Influenza a H5N1
Creator: SpendQuery
License: https://www.usa.gov/government-works

RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1

Delivery Order · Office of Assistant Secretary for Preparedness and Response · to Lovelace Biomedical Research Institute (UEI MBT9RXJJ7428) · data as of 2026-10-20

Obligated to date$3.72M1 action

Current value$3.72Mwith options exercised

Period2026-08-26 → 2028-04-25current end date

Up for re-bid: ends 2028-04-25. Recompete brief →

What it is

Product or service: Health R&D Services; Health Care Services; Experimental Development (PSC AN13)
Industry: Research and Development in Biotechnology (Except Nanobiotechnology) (NAICS 541714)
Contracting office: Barda - Aspr / Daappo / Barda Dcma (75A501)
Competition: Full and open competition
Pricing: Cost plus fixed fee
How it was bought: Single-award IDIQ · under 75A50122D00021
Solicitation: RTOR-BIO-AMT-2312
Where the work is: Bernalillo, NM · district NM-01

Obligations by fiscal year

FY2026$3.72M

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

1 action since 2026-08-21. Each is a modification or amendment with the money it added or took back.

Date	Modification	Kind	Amount	What the agency wrote
2026-08-21	0		$3.72M	RTOR BIO-AMT-2312: ASSESSMENT OF THE THERAPEUTIC POTENTIAL OF CHLOROQUINE AND OSELTAMIVIR IN TWO (2) LETHAL MODELS OF INFLUENZA A H5N1

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-20). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗

Putting the award page together from the records…